跳至主要内容
临床试验/CTRI/2011/08/001965
CTRI/2011/08/001965已完成4 期

A single-blind randomized controlled clinical study comparing the efficacy, tolerability and safety of levocetrizine and olopatadine in chronic urticaria - ESLO

Burdwan Medical College and Hospital0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age above 18 years
  • 2. Patients of either sex
  • 3. Patients suffering from urticaria for more than 6 weeks

排除标准

  • 1Pregnant or nursing women
  • 2End stage renal disease
  • 3Patients having immunosuppression due to drug or disease
  • 4History of alcohol or substance abuse
  • 5Subjects working in night-shifts or are likely to change the usual sleep/wake cycle.
  • 6Patients driving automobiles.
  • 7Participation in any other clinical trial within past 3 months
  • 8Patients unwilling to provide written informed consent or unlikely to comply with the trial protocol
  • 9Any other condition, which in the opinion of the investigators, is not conducive to inclusion of the subject in the trial

研究者

发起方
Burdwan Medical College and Hospital

相似试验